Zomedica - מכפיל EV/EBITDA ZOM

This EV/EBITDA chart for Zomedica Corp. (ZOM) illustrates a business valuation that currently stands at . Zomedica Corp. (ZOM) leads the development of optical biosensors and Truforma portable systems. The integration of diagnostics with PulseVet devices creates a closed-loop therapy cycle for clinics. Operational efficiency is further enhanced by a streamlined equipment distribution network via internal warehouses, eliminating supply chain disruptions.

Investors utilize this metric for comparative asset analysis to determine a business's fair value relative to its operating profit. The calculation combines market capitalization and net debt, benchmarking them against EBITDA to assess the enterprise's real value while excluding tax and depreciation effects. High development costs for Truforma make the EV/EBITDA multiple for Zomedica Corp. (ZOM) a key tool for monitoring overpayment for technological leadership.